Health & Fitness

According to FutureWise analysis, the liver cancer therapeutics market in 2025 is US$4.08 billion, and is expected to reach US$15.79 billion by 2033 at a CAGR of 18.43%.  The liver cancer therapeutics market is currently witnessing notable growth, driven by the increasing global prevalence of hepatocellular carcinoma, which is frequently linked to infections from hepatitis B and C, as well as alcohol-related liver disease and non-alcoholic fatty liver disease. The advent of innovative immunotherapy drugs, including checkpoint inhibitors and combination therapies, is reshaping treatment approaches and significantly enhancing patient survival rates. Additionally, the emergence of targeted therapies such as tyrosine kinase inhibitors and monoclonal antibodies has expanded treatment options beyond the traditional chemotherapy methods. The movement towards precision medicine, supported by biomarker testing and genetic profiling, is paving the way for more personalized and effective ... Continue reading →

According to FutureWise analysis the market for long term care devices in 2025 is US$ 231.57 billion, and is expected to reach US$ 426.49 billion by 2033 at a CAGR of 7.93%. This growth is fueled by an aging population and the rise of chronic diseases, leading to greater demand for long-term care. Technological advancements in remote monitoring and smart devices are improving patient independence and care quality, while the shift toward home-based care is driving the adoption of long-term care devices globally. Long-term care devices are essential tools designed to assist individuals who need ongoing support due to various factors such as aging, chronic illnesses, disabilities, or reduced mobility. These devices aim to promote independence, safety, and a high quality of life for patients, while also alleviating the physical and emotional strain often experienced by caregivers. As the global population shifts towards an older demographic and life expectancy increases, the demand for ... Continue reading →

According to FutureWise analysis, the Liver Cirrhosis Treatment market in 2025 is US$7.65 billion, and is expected to reach US$17.03 billion by 2033 at a CAGR of 10.52%.  The Liver Cirrhosis Treatment market is experiencing significant growth due to the rising prevalence of chronic liver diseases, including alcoholic liver disease, non-alcoholic steatohepatitis (NASH), and viral hepatitis infections worldwide. The increasing burden of lifestyle-related risk factors such as obesity, diabetes, and excessive alcohol consumption is leading to higher rates of cirrhosis in both developed and emerging markets. Recent advancements in antifibrotic therapies and disease-modifying treatments offer new hope for slowing disease progression and reducing complications. There is also a growing emphasis on early diagnosis through non-invasive technologies, allowing for timely intervention and improved patient outcomes. Additionally, the expanding pipeline of novel therapeutics targeting ... Continue reading →

According to FutureWise analysis, the low profile additive market in 2025 is US$ 0.76 billion and is expected to reach US$ 1.58 billion by 2033 at a CAGR of 9.58%. The market growth is fueled by the rising demand for high-quality composite materials with excellent surface finish and dimensional stability in automotive, construction, and electrical sectors. The shift towards lightweight composites for better fuel efficiency, along with advancements in resin and polymer technologies, is driving expansion. Additionally, investments in sustainable, low-emission composite manufacturing are supporting ongoing demand for low profile additives. Low Profile Additives (LPAs) are specialized materials utilized primarily in composite manufacturing to enhance surface quality and dimensional stability during the curing phase. These additives are commonly integrated into thermoset resin systems, which include polyester, vinyl ester, and epoxy resins. Their primary purpose is to minimize surface ... Continue reading →

According to FutureWise analysis, the long read sequencing market in 2025 is US$0.81 billion, and is expected to reach US$1.64 billion by 2033 at a CAGR of 9.22%. Long-read sequencing, also known as third-generation sequencing, is a DNA sequencing technique that addresses key challenges in genomics, such as throughput, coverage, and precision. This method offers several advantages over short-read sequencing. While short-read sequencers typically generate reads of up to 600 bases, long-read sequencing can produce reads exceeding 10,000 bases. The widespread adoption of long-read sequencing technology is poised to enhance our understanding of pathogen evolution, cancer, genetic diversity, and drug resistance in complex genomic regions that are critical for clinical care. Additionally, the alopecia areata market is being driven by an increase in the incidence of autoimmune diseases, such as type 1 diabetes and rheumatoid arthritis. The growth of the alopecia areata market is ... Continue reading →

According to FutureWise analysis, the Lyophilized Injectable Drugs market in 2025 is US$0.61 billion, and is expected to reach US$0.96 billion by 2033 at a CAGR of 5.83%.  The lyophilized injectable drugs market is currently experiencing robust growth, fueled largely by the increasing demand for biologics and biosimilars. These products often rely on lyophilization, or freeze-drying, to ensure their stability and extend their shelf life. The freeze-drying process is essential for preserving the integrity of heat-sensitive pharmaceutical compounds, including a range of antibiotics, vaccines, and monoclonal antibodies. This preservation method not only allows for long-term storage but also facilitates global distribution, making these vital medications more accessible worldwide. As the landscape of oncology and immunology therapeutics evolves, the adoption of lyophilized formulations is expanding, creating a wealth of new market opportunities. These formulations are ... Continue reading →

According to FutureWise analysis, the lung cancer diagnostics market in 2025 is US$ 13.82 billion and is expected to reach US$ 24.19 billion by 2033 at a CAGR of 7.25%. The growth is fueled by the rising global burden of lung cancer, increased awareness of early detection, and the adoption of advanced diagnostic technologies like molecular diagnostics, liquid biopsy, and AI-imaging. Improvements in companion diagnostics and personalized medicine allow for more accurate diagnosis and targeted treatments, while expanding screening programs and investments in oncology diagnostics contribute to market growth. Lung cancer diagnostics are essential for the early detection, accurate diagnosis, and effective management of one of the most common and lethal cancers globally. In its initial stages, lung cancer often exhibits subtle or non-specific symptoms, which can result in delayed diagnoses and poorer prognoses. Consequently, the development of robust and advanced diagnostic solutions is ... Continue reading →

According to FutureWise analysis the market for Lung Cancer Liquid Biopsy in 2025 is US$ 0.62 billion, and is expected to reach US$ 1.93 billion by 2033 at a CAGR of 15.25%. Strong growth is fueled by the rising adoption of non-invasive liquid biopsy techniques for early lung cancer detection and treatment. Advances in circulating tumor DNA analysis, next-generation sequencing, and companion diagnostics are enhancing sensitivity and clinical utility. The demand for personalized oncology care and increased validation of liquid biopsy assays are further driving market expansion. Liquid biopsy is becoming an essential component of precision medicine, significantly impacting diagnostics and treatment strategies in oncology. This innovative approach allows healthcare providers to analyze a simple blood sample to detect diseases or tumors at an early stage. By examining circulating cancer cells or genetic material—such as RNA or DNA—found in the bloodstream, clinicians can ... Continue reading →

According to FutureWise analysis the market for lung cancer screening in 2025 is US$ 1.14 billion, and is expected to reach US$ 1.99 billion by 2033 at a CAGR of 7.21%. Growth in low-dose computed tomography (LDCT) screening is driven by higher adoption among high-risk groups, like long-term smokers. Increased awareness of early lung cancer detection benefits, along with government support and updated guidelines, is encouraging this trend. Additionally, advancements in AI-assisted imaging are improving screening accuracy and efficiency. Lung cancer screening is a crucial preventive healthcare strategy focused on the early detection of lung cancer, especially in high-risk groups. It addresses lung cancer, which is one of the leading causes of cancer-related deaths globally, often due to diagnoses occurring at late stages when treatment options are limited. Screening programs aim to identify the disease before symptoms develop, which can significantly enhance survival rates and decrease ... Continue reading →

Loss of a loved one can bring about extreme pain and sorrow for the family, and if the dead body needs to be brought to a specific location within a given time, it becomes a distressing situation to find an appropriate solution. Contacting the team of Panchmukhi Body Freezer Mortuary Box Transportation in Delhi would be of immense help, as it would allow taking the dead body to the selected destination without any difficulties due to the availability of ice and freezer box techniques. Our team understands that customizing hearse vans can help create a meaningful and memorable tribute to the deceased individuals and we manage to deliver services that are especially designed for your convenience. We help with the loading, unloading, and embalming of the dead bodies while they are being transferred to their selected destination. The best support is offered depending upon your needs at Dead Body Transportation in Delhi having facilities that allow completing the process effectively. ... Continue reading →